The Indian Institute of Technology Kanpur (IITK) has entered into a Memorandum of Agreement (MOA) with Laurus Labs to introduce gene therapy assets to the marke 19 June 2023
Verve Therapeutics is a clinical-stage genetic medicines company that claims to be pioneering a new approach to the care of cardiovascular disease. 16 June 2023
US biotech major Gilead Sciences’ recent investments into oncology—including its $11.9 billion acquisition of Kite Pharma in 2017—have made the company one of t 6 June 2023
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.